Market News & Trends
Monopar Announces Completion of Phase 2b Enrollment & Commencement of Phase 3 Enrollment in its VOICE Trial for Severe Oral Mucositis
Monopar Therapeutics Inc. recently announced an update on its actively enrolling Validive Phase 2b/3 VOICE clinical trial for the prevention of severe oral mucositis (SOM)…
MBX Biosciences Advances Phase 1 Clinical Trial of Long-Acting Parathyroid Hormone Peptide Prodrug
MBX Biosciences, Inc. recently announced it has initiated the multiple ascending dose portion of its ongoing Phase 1 clinical trial of MBX 2109. MBX 2109,…
Thermo Fisher Scientific Introduces Decentralized Clinical Trials Network
The PPD clinical research business of Thermo Fisher Scientific Inc. recently announced the creation of the PPD DCT Network to support global investigators and research…
Icosavax Initiates Phase 1 Trial of IVX-A12 Against RSV & hMPV in Older Adults
Icosavax, Inc. recently announced the initiation of a Phase 1 clinical trial of IVX-A12, a combination bivalent RSV and hMPV VLP vaccine candidate, in older…
Nutriband & Kindeva Drug Delivery Demonstrate Enhanced Abuse-Deterrent Characteristics for Aversa Fentanyl
Nutriband Inc. and Kindeva Drug Delivery have demonstrated enhanced abuse deterrence kinetics of the company’s patented lead product, Aversa Fentanyl, an abuse-deterrent fentanyl transdermal system….
Ascendia Pharmaceuticals Named to Inc. 5000 List of America’s Fastest-Growing Private Companies for Third Consecutive Year
Ascendia Pharmaceuticals recently announced it has been named to the prestigious Inc. 5000 rankings of the fastest growing privately-owned companies in the United States for…
Alexion, AstraZeneca Rare Disease to Acquire LogicBio Therapeutics to Accelerate Growth in Genomic Medicine
LogicBio Therapeutics, Inc. recently announced it has entered into a definitive agreement under which AstraZeneca Rare Disease will acquire LogicBio. The proposed acquisition…
Biogen & Denali Therapeutics Announce Initiation of Phase 3 LIGHTHOUSE Study in Parkinson’s Disease Associated With LRRK2 Pathogenic Mutations
Biogen Inc. and Denali Therapeutics Inc. recently announced dosing has commenced in the global Phase 3 LIGHTHOUSE study to evaluate the efficacy and safety profile…
Zealand Pharma Announces Positive Results from Phase 3 Trial of Glepaglutide in Patients With Short Bowel Syndrome (EASE 1)
Zealand Pharma A/S recently announced positive topline results from the pivotal Phase 3 trial of glepaglutide, a long-acting GLP-2 analogue designed for once or twice…
Spectradyne Launches New ARC Particle Analyzer
Spectradyne recently launched its second-generation product, the ARC particle analyzer. Spectradyne’s ARC is a ground-breaking technology for analyzing biological nanoparticles in complex….
Thermo Fisher Scientific Announces FDA Approval of Oncomine Dx Target Test as the First NGS-Based Companion Diagnostic to Aid in Therapy Selection for Patients with RET Mutations/Fusions in Thyroid Cancers
The US FDA has granted approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic (CDx) to aid in selection of patients…
NJIT Researchers Unlock a New Method for Testing Protein-Based Drugs
New Jersey Institute of Technology researchers have unveiled a new lab technique they say represents a “paradigm shift” in how pharmaceutical laboratories test and produce…
BD Launches State-of-the-Art Cloud Software Solution to Streamline Flow Cytometry Research
BD (Becton, Dickinson and Company) recently launched BD® Research Cloud, a cloud-based software solution designed to streamline the flow cytometry workflow to enable higher….
Cornerstone Pharmaceuticals Initiates Phase 1 Trial of CPI-613 in Combination With Chemoradiation for the Treatment of Advanced Pancreatic Cancer
Cornerstone Pharmaceuticals, Inc. recently announced the initiation of a Phase 1 clinical trial evaluating CPI-613 (devimistat) in combination with chemoradiation for the treatment of advanced…
Cara Therapeutics Announces Difelikefalin Injection NDA Has Been Submitted in Japan
Cara Therapeutics, Inc. recently announced its licensing partner Maruishi Pharmaceutical Co., Ltd. submitted a New Drug Application (NDA) in Japan for approval of difelikefalin for…
KemPharm Announces Positive Topline Data from Phase 1 Clinical Trial Evaluating Cardiovascular Safety of Serdexmethylphenidate
KemPharm, Inc. recently announced topline data from its exploratory Phase 1 clinical trial confirming the relative cardiovascular effects and pharmacokinetics of serdexmethylphenidate (SDX) compared to…
Actylis Debuts, Signaling the Creation of an Integrated Global Specialty Ingredients Manufacturing & Sourcing Powerhouse
Actylis, a leading global manufacturer and sourcing expert of critical raw materials and performance ingredients for the life sciences and specialty chemicals markets, recently made its debut…..
Wheeler Bio Announces President & Chief Operating Officer
Wheeler Bio, a new CDMO specializing in the cell line development, process development, and small batch clinical production of antibodies, has announced the appointment of….
SCHOTT Pharma Expands Cartridge Production in China & Hungary
SCHOTT Pharma is again announcing plans to expand its manufacturing facilities: With a double-digit million Euro investment, the company aims to significantly increase its production…
Bora Pharmaceuticals Partners With TaiRx to Manufacture Breakthrough Anti-Cancer Drug
Bora Pharmaceutical Laboratories Inc., a division of Bora Pharmaceuticals, has partnered with TaiRx, Inc., a premier Taiwan new drug development company, to manufacture a novel anti-cancer drug, CVM-1118. ….
